{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T01:58:32Z","timestamp":1770688712184,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,9,17]],"date-time":"2015-09-17T00:00:00Z","timestamp":1442448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s11655-015-2084-7","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T04:54:25Z","timestamp":1442552065000},"page":"362-369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Anticancer effects of crude extract from Melia toosendan Sieb. et Zucc on hepatocellular carcinoma in vitro and in vivo"],"prefix":"10.1007","volume":"22","author":[{"given":"Xiao-ling","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-juan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,9,17]]},"reference":[{"key":"2084_CR1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0006-8993(99)02129-0","volume":"850","author":"YL Shi","year":"1999","unstructured":"Shi YL, Chen WY. Effect of toosendanin on acetylcholine level of rat brain, a microdialysis study. Brain Res 1999;850:173\u2013178.","journal-title":"Brain Res"},{"key":"2084_CR2","first-page":"714","volume":"30","author":"Y Tang","year":"2004","unstructured":"Tang Y, Guo H, Hu DB, Zhang Ji. A study of ultrasoundassisted extraction of toosendanin with water from bark of melia toosendan sieb. T zucc. J Southwest Univ Natl (Nat Sci Ed, Chin) 2004;30:714\u2013717.","journal-title":"J Southwest Univ Natl (Nat Sci Ed"},{"key":"2084_CR3","first-page":"79","volume":"25","author":"P Jiang","year":"2005","unstructured":"Jiang P, An XN. Comparative study on extraction methods of toosendanin. Chem Ind Forest Prod (Chin) 2005;25:79\u201382.","journal-title":"Chem Ind Forest Prod (Chin)"},{"key":"2084_CR4","first-page":"35","volume":"33","author":"CC Chung","year":"1975","unstructured":"Chung CC, Hsie TH, Chen SF, Liang HT. The structure of Chuanliansu (toosendanin). Acta Chim Sin (Chin) 1975;33:35\u201347.","journal-title":"Acta Chim Sin (Chin)"},{"key":"2084_CR5","first-page":"196","volume":"38","author":"GX Shu","year":"1980","unstructured":"Shu GX, Liang XT. A correction of the structure of Chuanliansu. Acta Chim Sin (Chin) 1980;38:196\u2013198.","journal-title":"Acta Chim Sin (Chin)"},{"key":"2084_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2007.02.002","volume":"82","author":"YL Shi","year":"2007","unstructured":"Shi YL, Li MF. Biological effects of toosendanin, a triterpenoid extracted from Chinese traditional medicine. Prog Neurobiol 2007;82:1\u201310.","journal-title":"Prog Neurobiol"},{"key":"2084_CR7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0014-5793(03)01291-2","volume":"555","author":"JY Zhou","year":"2003","unstructured":"Zhou JY, Wang ZF, Ren XM, Tang MZ, Shi YL. Antagonism of botulinum toxin type A-induced cleavage of SNAP-25 in rat cerebral synaptosome by toosendanin. FEBS Lett 2003;555:375\u2013379.","journal-title":"FEBS Lett"},{"key":"2084_CR8","first-page":"839","volume":"25","author":"YL Shi","year":"2004","unstructured":"Shi YL, Wang ZF. Cure of experimental botulism and antibotulismic effect of toosendanin. Acta Pharmacol Sin 2004;25:839\u2013848.","journal-title":"Acta Pharmacol Sin"},{"key":"2084_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tox.2004.03.023","volume":"201","author":"MZ Tang","year":"2004","unstructured":"Tang MZ, Wang ZF, Shi YL. Involvement of cytochrome c release and caspase activation in toosendanin-induced PC12 cell apoptosis. Toxicology 2004;201:31\u201338.","journal-title":"Toxicology"},{"key":"2084_CR10","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10637-005-0909-5","volume":"23","author":"B Zhang","year":"2005","unstructured":"Zhang B, Wang ZF, Tang MZ, Shi YL. Growth inhibition and apoptosis-induced effect on human cancer cells of toosendanin, a triterpenoid derivative from Chinese traditional medicine. Invest New Drugs 2005;23:547\u2013553.","journal-title":"Invest New Drugs"},{"key":"2084_CR11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000079339","volume":"13","author":"JC Yu","year":"2004","unstructured":"Yu JC, Min ZD, LP NY. Melia toosendan regulates PC12 cell differentiation via the activation of protein kinase A and extracellular signal-regulated kinases. Neurosignals 2004;13:248\u2013257.","journal-title":"Neurosignals"},{"key":"2084_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0029-1240671","volume":"76","author":"YJ He","year":"2010","unstructured":"He YJ, Wang J, Liu XL, Zhang L, Yi G, Li CW, et al. Toosendanin inhibits hepatocellular carcinoma cells by inducing mitochondria-dependent apoptosis. Planta Med 2010;76:1\u20137.","journal-title":"Planta Med"},{"key":"2084_CR13","first-page":"24","volume":"13","author":"J Zhou","year":"1982","unstructured":"Zhou J, Jia GR, He XY. Pharmacokinetics researches of toosendanin. Chin Herb Med (Chin) 1982;13:24\u201326.","journal-title":"Chin Herb Med (Chin)"},{"key":"2084_CR14","first-page":"29","volume":"13","author":"PZ Li","year":"1982","unstructured":"Li PZ, Shi XC, Xue ZH, Li JF, Sun GZ, Qin BY. Researches on pharmacological and toxicological effects of toosendanin. Chin Herb Med (Chin) 1982;13:29\u201332.","journal-title":"Chin Herb Med (Chin)"},{"key":"2084_CR15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tox.2008.04.005","volume":"249","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Qi X, Gong L, Li Y, Liu L, Xue X, et al. Roles of reactive oxygen species and MAP kinases in the primary rat hepatocytes death induced by toosendanin. Toxicology 2008;249:62\u201368.","journal-title":"Toxicology"},{"key":"2084_CR16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/ptr.2159","volume":"21","author":"SJ Uddin","year":"2007","unstructured":"Uddin SJ, Nahar L, Shilpi JA, Shoeb M, Borkowski T, Gibbons S, et al. Gedunin, a limonoid from Xylocarpus granatum, inhibits the growth of CaCo-2 colon cancer cell line in vitro. Phytother Res 2007;21:757\u2013761.","journal-title":"Phytother Res"},{"key":"2084_CR17","first-page":"276","volume":"17","author":"Y Tang","year":"2005","unstructured":"Tang Y, Liu SM, Hu DB, Guo H, Zhang J, Li F. Determination of toosendain in the bark of melia toosendan sieb. et Zuccc by reversed-phase high performance liquid chromatography. Chem Res Applic (Chin) 2005;17:276\u2013278.","journal-title":"Chem Res Applic (Chin)"},{"key":"2084_CR18","first-page":"12","volume":"3","author":"XF Zhang","year":"2004","unstructured":"Zhang XF, Zhang SF. Acute LD50 determination of toosendanin in mice by ip injection. J Tradit Chin Veterin Med (Chin) 2004;3:12\u201313.","journal-title":"J Tradit Chin Veterin Med (Chin)"},{"key":"2084_CR19","doi-asserted-by":"crossref","first-page":"45826","DOI":"10.1074\/jbc.M309024200","volume":"278","author":"O Peyruchaud","year":"2003","unstructured":"Peyruchaud O, Serre CM, NicAmhlaoibh R, Fournier P, Clezardin P. Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity. J Biol Chem 2003;278:45826\u201345832.","journal-title":"J Biol Chem"},{"key":"2084_CR20","first-page":"23","volume":"24","author":"P Jiang","year":"2004","unstructured":"Jiang P, Ye HL, An XN. Studies on extraction of extractives from Melia azedarach L. and its bacteriostatic activity. Chem Ind Forest Prod 2004;24:23\u201327.","journal-title":"Chem Ind Forest Prod"},{"key":"2084_CR21","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35077213","volume":"411","author":"GI Evan","year":"2001","unstructured":"Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342\u2013348.","journal-title":"Nature"},{"key":"2084_CR22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1021\/np9604893","volume":"60","author":"GM Cragg","year":"1997","unstructured":"Cragg GM, Newman DJ, Snader KM. Natural products in drug discovery and development. J Nat Prod 1997;60:52\u201360.","journal-title":"J Nat Prod"},{"key":"2084_CR23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0378-4274(99)00252-0","volume":"112-113","author":"K Debatin","year":"2000","unstructured":"Debatin, K. Activation of apoptosis pathways by anticancer treatment. Toxicol Lett 2000;112-113:41\u201348.","journal-title":"Toxicol Lett"},{"key":"2084_CR24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/excr.2000.4838","volume":"256","author":"SH Kaufmann","year":"2000","unstructured":"Kaufmann SH, Earnshaw WC. Induction of apoptosis by cancer chemotherapy. Exp Cell Res 2000;256:42\u201349.","journal-title":"Exp Cell Res"},{"key":"2084_CR25","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1128\/MCB.10.10.5502","volume":"10","author":"J Cheng","year":"1990","unstructured":"Cheng J, Haas M. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 1990;10:5502\u20135509.","journal-title":"Mol Cell Biol"},{"key":"2084_CR26","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.7973635","volume":"266","author":"SW Lowe","year":"1994","unstructured":"Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, et al. p53 status and the efficacy of cancer therapy in vivo. Science 1994;266:807\u2013810.","journal-title":"Science"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-015-2084-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11655-015-2084-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-015-2084-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T19:00:51Z","timestamp":1559415651000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11655-015-2084-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,17]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["2084"],"URL":"https:\/\/doi.org\/10.1007\/s11655-015-2084-7","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,17]]}}}